Tag Ibrutinib

Ibrutinib (Ibruxen) is used to treat blood cancer like lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), Waldenström macroglobulinemia (WM), and marginal zone lymphoma (MZL).